We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$5.13B
(-23%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$147M |
| 2 |
Y
Alleghany Corp
Y
|
+$137M |
| 3 |
Applied Materials
AMAT
|
+$116M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Royal Bank of Canada
RY
$282B
| $7.47M | 0.04% |
+67,150
| New | +$6.87M |
|
202
Western Alliance Bancorporation
WAL
$8.77B
| $7.42M | 0.04% |
105,137
-52,651
| -33% | -$4.03M |
|
203
Enterprise Financial Services Corp
EFSC
$2.32B
| $7.27M | 0.04% |
175,141
-44,725
| -20% | -$1.99M |
|
204
Coursera
COUR
$1.41B
| $7.23M | 0.04% |
+510,170
| New | +$9.1M |
|
|
SIVB
205
DELISTED
SVB Financial Group
SIVB
| $7.14M | 0.04% |
18,066
-11,629
| -39% | -$5.48M |
|
206
Teck Resources
TECK
$31.6B
| $7.13M | 0.04% |
233,227
+37,146
| +19% | +$1.47M |
|
207
BILL Holdings
BILL
$4.14B
| $7.1M | 0.04% |
+64,609
| New | +$9.4M |
|
|
MORF
208
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.05M | 0.04% |
325,000
| – | – |
|
|
FRC
209
DELISTED
First Republic Bank
FRC
| $7.01M | 0.04% |
+48,607
| New | +$7.29M |
|
210
Amgen
AMGN
$204B
| $6.99M | 0.04% |
28,717
| – | – |
|
|
AVDL
211
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.86M | 0.04% |
2,812,490
-386,662
| -12% | -$1.59M |
|
212
Walmart Inc
WMT
$865B
| $6.6M | 0.04% |
+162,867
| New | +$7.51M |
|
213
Okta
OKTA
$32.7B
| $6.37M | 0.04% |
70,470
-459,003
| -87% | -$49.6M |
|
214
MP Materials
MP
$8.86B
| $6.09M | 0.04% |
189,884
+50,172
| +36% | +$2.02M |
|
215
Blackstone
BX
$95.6B
| $6.09M | 0.04% |
66,722
-24,341
| -27% | -$2.63M |
|
|
MODV
216
DELISTED
ModivCare
MODV
| $6.08M | 0.04% |
71,943
-2,182
| -3% | -$220K |
|
217
CS Disco
LAW
$273M
| $6.04M | 0.04% |
334,708
+160,089
| +92% | +$4.13M |
|
218
Chemed
CHE
$6.59B
| $6M | 0.04% |
12,773
-766
| -6% | -$374K |
|
219
Sabre
SABR
$868M
| $5.82M | 0.03% |
997,489
+492,501
| +98% | +$4.11M |
|
220
S&P Global
SPGI
$121B
| $5.8M | 0.03% |
17,198
-46,570
| -73% | -$16.6M |
|
221
Summit Therapeutics
SMMT
$14.2B
| $5.6M | 0.03% |
5,599,407
-673,102
| -11% | -$944K |
|
|
SYNH
222
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.5M | 0.03% |
76,696
-4,705
| -6% | -$344K |
|
223
Albemarle
ALB
$13.5B
| $5.46M | 0.03% |
26,115
+18,132
| +227% | +$4.05M |
|
224
Medtronic
MDT
$119B
| $5.11M | 0.03% |
56,945
-172,643
| -75% | -$17.5M |
|
225
Take-Two Interactive
TTWO
$40.5B
| $5.05M | 0.03% |
41,258
+10,034
| +32% | +$1.28M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.